Micro Labs

Bengaluru, known globally as India’s IT capital, is now fast emerging as a powerful hub for pharma and life sciences. With its…

The final panel discussion on Day 2 of the FDD Conclave 2025 focused on how formulation science can evolve to better serve special…

Drug delivery is undergoing a transformation driven by the demand for patient-friendly, painfree alternatives. As pharma R&D…

The funds raised will be utilised to enable several key initiatives like pre-clinical testing of CAR-NK and CAR-gamma delta T cell…

As COVID-19 continues to extract its price, will a more aware patient pool build up public opinion and turn the tide?

The annual sales of Dolo 650 have been Rs 360 crore, about eight per cent of the company sales

Dilip Surana, CMD, Micro Labs and his leadership team recount how early brushes with regulatory censure helped future-proofed…

The drug comes in two strengths ZUCAPRIDE–M 500 priced at Rs12.80 per tablet and ZUCAPRIDE–M 1000 at Rs 14.80

The transaction is Advent’s sixth investment in the healthcare sector and seventh investment in India over the past twelve months